Results 181 to 190 of about 23,600 (247)
Some of the next articles are maybe not open access.

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Lancet Oncology, The, 2019
BACKGROUND Both single-agent ibrutinib and chlorambucil plus obinutuzumab have shown superior efficacy to chlorambucil monotherapy and are standard first-line treatments in chronic lymphocytic leukaemia.
Carol Moreno   +2 more
exaly   +2 more sources

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial.

The Lancet Oncology, 2020
BACKGROUND Venetoclax plus obinutuzumab has been established as a fixed-duration treatment regimen for patients with chronic lymphocytic leukaemia.
O. Al-Sawaf   +25 more
semanticscholar   +1 more source

Temperature‐responsive voltammetric sensor based on stimuli-sensitive semi-interpenetrating polymer network conductive microgels for reversible switch detection of nitrogen mustard analog chlorambucil (Leukeran™)

, 2021
In this study, we report the synthesis of thermosensitive poly(N-vinylcaprolactam) semi-interpenetrated conductive polypyrrole microgels (PVCL/PPY semi-IPN MGs) for “on-off” switchable electrochemical sensing of carcinogenic nitrogen mustard drug ...
B. Mutharani   +3 more
semanticscholar   +1 more source

Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.

, 2021
7509Background: Early results from ELEVATE-TN (NCT02475681) at a median follow-up of 28.3 mo demonstrated superior efficacy of acalabrutinib (A) ± obinutuzumab (O) compared with O + chlorambucil (C...
J. Sharman   +19 more
semanticscholar   +1 more source

A peptide-drug hydrogel to enhance the anti-cancer activity of chlorambucil.

Biomaterials Science, 2020
The clinical applications of nitrogen mustard antitumor drugs are limited by their poor aqueous solubility, poor cellular uptake, lack of targeting, and severe side effects.
Qingxiang Guo   +6 more
semanticscholar   +1 more source

Enzyme-responsive sulfatocyclodextrin/prodrug supramolecular assembly for controlled release of anti-cancer drug chlorambucil.

Chemical Communications, 2019
Supramolecular drug delivery systems are becoming an increasingly important part in controlled drug release. In this work, we report a novel enzyme-responsive supramolecular assembly directly constructed using biocompatible sulfato-β-cyclodextrin (SCD ...
X. Guan   +4 more
semanticscholar   +1 more source

Redox-Driven Disassembly of Polymer–Chlorambucil Polyprodrug: Delivery of Anticancer Nitrogen Mustard and DNA Alkylation

ACS Applied Polymer Materials, 2019
Utilization of nitrogen mustards as anticancer drugs opened the way for precise cancer chemotherapy owing to their ability to cross-link deoxyribonucleic acid (DNA).
B. Saha   +4 more
semanticscholar   +1 more source

Evaluating Ternary Metal Oxide (TMO) core-shell nanocomposites for the rapid determination of the anti-neoplastic drug Chlorambucil (Leukeran™) by electrochemical approaches.

Materials Science and Engineering C: Materials for Biological Applications, 2019
A functional ternary nanocomposite (MnO2@NiFe2O4) with hierarchically grown flower-like core-shell assembly has been prepared through a simple two-step hydrothermal methodology.
Kogularasu Sakthivel   +5 more
semanticscholar   +1 more source

Supramolecular Hydrogel Based on Chlorambucil and Peptide Drug for Cancer Combination Therapy.

ACS Applied Materials and Interfaces, 2018
Supramolecular hydrogels of self-assembling peptide-drug conjugates have been considered as effective self-delivery drug systems for cancer therapy in recent years.
Lijun Yang   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy